𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy

✍ Scribed by L.T. Goodnough; T.H. Price; K.D. Friedman; M. Johnston; D. Ciavarella; N. Khan; R. Sacher; W.R. Vogler; M. Wissel; R.I. Abels


Book ID
114439718
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
542 KB
Volume
34
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.